These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1097545

  • 21. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F, Raab W.
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract] [Full Text] [Related]

  • 22. Amphotericin B and 5-fluorocytosine penetration into blood and fibrin clots.
    Rubinstein E.
    Chemotherapy; 1979 May; 25(5):249-53. PubMed ID: 573195
    [Abstract] [Full Text] [Related]

  • 23. Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B.
    Kaspar RL, Drutz DJ.
    Antimicrob Agents Chemother; 1975 Apr; 7(4):462-5. PubMed ID: 1096801
    [Abstract] [Full Text] [Related]

  • 24. Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus.
    Kitahara M, Seth VK, Medoff G, Kobayashi GS.
    Antimicrob Agents Chemother; 1976 Jun; 9(6):915-9. PubMed ID: 820247
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ, DeLallo VC, Lewis RE, Ernst EJ, Klepser ME.
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [Abstract] [Full Text] [Related]

  • 26. Proceedings: Synergism between 5-fluorocytosine and polyene antibiotics.
    Polak A.
    Pathol Microbiol (Basel); 1975 Nov; 42(4):234-5. PubMed ID: 778764
    [No Abstract] [Full Text] [Related]

  • 27. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine.
    Richardson MD, Paton M, Shankland GS.
    Mycoses; 1991 Nov; 34(5-6):201-4. PubMed ID: 1795714
    [Abstract] [Full Text] [Related]

  • 28. Combined effect of amphotericin B and flucytosine on hyphal growth of Candida albicans estimated at a single hypha level.
    Oh KB, Yang HC, Matsuoka H, Yamamoto A, Kurata H.
    J Med Vet Mycol; 1995 Nov; 33(3):191-5. PubMed ID: 7666300
    [Abstract] [Full Text] [Related]

  • 29. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G, Manzara S, Dettori G.
    Chemotherapy; 1991 Nov; 37(1):23-31. PubMed ID: 2013239
    [Abstract] [Full Text] [Related]

  • 30. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
    de Resende MA.
    Rev Inst Med Trop Sao Paulo; 1979 Nov; 21(6):344-6. PubMed ID: 550288
    [No Abstract] [Full Text] [Related]

  • 31. Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice.
    Rabinovich S, Shaw BD, Bryant T, Donta ST.
    J Infect Dis; 1974 Jul; 130(1):28-31. PubMed ID: 4601179
    [No Abstract] [Full Text] [Related]

  • 32. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract] [Full Text] [Related]

  • 33. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G, Kobayashi GS.
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract] [Full Text] [Related]

  • 34. In vitro and in vivo antifungal activity of the combination methylpartricin-5-fluorocytosine.
    Strippoli V, Torosantucci A, Simonetti N.
    Chemioterapia; 1984 Apr; 3(2):119-25. PubMed ID: 6398120
    [Abstract] [Full Text] [Related]

  • 35. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G, Kobayashi GS, Kwan CN, Schlessinger D, Venkov P.
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of Candida albicans by amphotericin B in combination with 5-fluorocytosine.
    Beggs WH, Sarosi GA, Andrews FA.
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):559-62. PubMed ID: 4604617
    [No Abstract] [Full Text] [Related]

  • 37. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
    Rumler W, Heins S.
    Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
    [No Abstract] [Full Text] [Related]

  • 38. Comparative studies on the postantifungal effect produced by the synergistic interaction of flucytosine and amphotericin B on Candida albicans.
    Scalarone GM, Mikami Y, Kurita N, Yazawa K, Miyaji M.
    Mycopathologia; 1992 Dec; 120(3):133-8. PubMed ID: 1494357
    [Abstract] [Full Text] [Related]

  • 39. In vitro susceptibility testing of Candida isolates from clinical specimens to four antifungal agents.
    Ohkawa M, Tokunaga S, Takashima M, Nishikawa T, Hisazumi H, Fujita S, Wheat RW.
    Chemotherapy; 1990 Dec; 36(6):396-402. PubMed ID: 2292203
    [Abstract] [Full Text] [Related]

  • 40. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M, Winblad B, Anséhn S, Schönebeck J.
    Scand J Infect Dis; 1978 Dec; 10(1):87-90. PubMed ID: 345424
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.